首页> 外文OA文献 >Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers

【2h】

Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers

机译：错误：在慢性骨髓白血病中接受伊马替尼，达斯替尼或尼洛尼的男性患者的伴侣怀孕结果：法国网络药理治中心收集的报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Patrick Carlier; Maritza Markarian; Nathalie Bernard; Laurence Lagarce; Anne Dautriche; Johanna Béné; Nathalie Fouilhe Sam-Lai; Pirayeh Eftekhari;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers (vol 295, pg 269, 2017) [J] . Carlier Patrick, Markarian Maritza, Bernard Nathalie, Archives of gynecology and obstetrics. . 2017,第4期

机译：在慢性骨髓白血病接受伊马替尼，达斯替尼或尼洛替尼患者的男性患者的伴侣妊娠结局：法国网络药物检疫中心收集的报告（第295 Vol 295，PG 269,2017）
2. Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia (CML): reports collected by the French regional pharmacovigilance (PV) centers [J] . Markarian M., Carlier P., Bernard N., Fundamental & clinical pharmacology. . 2016,第Suppla1期

机译：在慢性髓性白血病（CML）中接受伊马替尼，达斯替尼或尼洛尼菌属的男性患者的伴侣孕孕：由法国区域药物检药（PV）中心收集的报告
3. Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Evaluation of Saglio G, Kim D-W, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010;362:2251-9, and Kantarjian H, Shah NP, Hochhaus A, et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2010;362:2260-70. [J] . Doggrell SA, Christensen AM Expert opinion on pharmacotherapy . 2011,第1期

机译：是否有比伊马替尼更好的Bcr-Abl激酶抑制剂用于慢性粒细胞白血病？ Saglio G，Kim D-W，Issaragrisil S等的评估。尼洛替尼与伊马替尼治疗新诊断的慢性粒细胞白血病。 N Engl J Med 2010; 362：2251-9，and Kantarjian H，Shah NP，Hochhaus A等。达沙替尼与伊马替尼治疗新近诊断的慢性期慢性粒细胞白血病。 N Engl J Med 2010; 362：2260-70。
4. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003

机译：对慢性期慢性粒细胞白血病患者甲磺酸伊马替尼的医师推荐的影响。
5. An economic analysis of high-dose imatinib dasatinib and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China [O] . Bin Wu, Maobai Liu, Te Li, -1

机译：大剂量伊马替尼达沙替尼和尼洛替尼治疗中国耐药伊马替尼慢性期慢性粒细胞白血病的经济分析
6. PCN172 Dasatinib, High-Dose Imatinib And Nilotinib In Chinese Patients With Chronic Phase Of Chronic Myeloid Leukemia With Imatinib-Resistance Or -Intolerance: An Economic Evaluation [O] . Wu B 2015

机译：PCN172达沙替尼，大剂量伊马替尼和尼洛替尼在中国慢性粒细胞白血病合并伊马替尼耐药或不耐受的慢性患者中的经济评价

Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers

著录项

引文网络

相似文献

相关主题

期刊订阅